Frederick A. Dressler

Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke.

OBJECTIVES We sought to determine the influence of plaque morphology and warfarin anticoagulation on the risk of recurrent emboli in patients with mobile aortic atheroma. BACKGROUND An epidemiologic link between aortic atheroma and systemic emboli has been described both in pathologic and transesophageal studies. Likewise, a few studies have found an increased incidence of recurrent emboli in these patients. The therapeutic implications of these findings has not been studied. METHODS Thirty-one patients presenting with a systemic embolic event and found to have mobile aortic atheroma were studied. The height, width and area of both immobile and mobile portions of atheroma were quantitated. The dimensions of the mobile component was used to define three groups: small, intermediate and large mobile atheroma. The patients were followed up by means of telephone interview and clinical records, with emphasis on anticoagulant use and recurrent embolic or vascular events. RESULTS Patients not receiving warfarin had a higher incidence of vascular events (45% vs. 5%, p = 0.006). Stroke occurred in 27% of these patients and in none of those treated with warfarin. The annual incidence of stroke in patients not taking warfarin was 0.32. Myocardial infarction occurred in 18% of patients also in this group. Taken together, the risk of myocardial infarction or stroke was significantly increased in this group (p = 0.001). Forty-seven percent of patients with small, mobile atheroma did not receive warfarin. Recurrent stroke occurred in 38% of these patients, representing an annual incidence of 0.61. There were no strokes in patients with small, mobile atheroma treated with warfarin (p = 0.04). Likewise, none of the patients with intermediate or large mobile atheroma had a stroke during follow-up. Only three of these patients had not been taking warfarin. CONCLUSIONS Patients presenting with systemic emboli and found to have mobile aortic atheroma on transesophageal echocardiography have a high incidence of recurrent vascular events. Warfarin is efficacious in preventing stroke in this population. The dimension of the mobile component of atheroma should not be used to determine the need for anticoagulation.

Relation between pulmonary venous flow and pulmonary wedge pressure: Influence of cardiac output

Multiple factors affect the systolic and diastolic components of pulmonary venous flow. It has been suggested that left ventricular function might influence the effects of filling pressures on indexes of pulmonary venous flow. The present study was designed to evaluate the effect of the pulmonary wedge pressures, left ventricular function, and cardiac output on the pulmonary vein flow pattern. Forty-five patients undergoing cardiac surgery were included in this study. Pulmonary venous flow and mitral flow variables were obtained by transesophageal echocardiography with hemodynamic variables obtained simultaneously. In the total group, there was no consistent relation between the pulmonary venous flow or the mitral flow parameters and the capillary wedge pressures. When patients were grouped according to normal (> 2.2 L/min/m2) or low (< 2.2 L/min/m2) cardiac index, a significant and positive relation was found between the systolic component of the pulmonary venous flow and the pulmonary wedge pressure in patients with normal cardiac index (r = 0.69; p = 0.003). Conversely, in patients with low cardiac index there was also a significant although negative correlation between the systolic velocity integral and the pulmonary wedge pressure (r = -0.58; p < 0.001). In conclusion, the systolic component of the pulmonary venous flow correlates closely and significantly with the capillary wedge pressures. The direction of this relation depends to a large extent on the total cardiac output and to a lesser extent on the left ventricular systolic function as assessed by the ejection fraction.

Valve replacement in the small aortic annulus: prospective randomized trial of St. Jude with Medtronic Hall

OBJECTIVE The ideal prosthesis for aortic valve replacement in patients with small annuli remains controversial and has yet to be identified. The purpose of this report is to compare the St. Jude (SJ) Medical and Medtronic Hall (MH) valves for aortic valve replacement in the small aortic root. METHODS From 1986 to 1994 we prospectively randomized 456 patients to receive either the SJ or the MH valve. From this population, 80 patients (SJ, 42 patients; MH 38 patients) had a 19 or 21 mm aortic prosthesis inserted without annulus enlarging procedure. RESULTS Follow-up was complete in all 80 patients for 270 patient years (mean 40.5 months). Analysis showed that the SJ and MH groups were similar with respect to age, gender, body surface area, valve area, NYHA class, ventricular function, prosthesis size, frequency of revascularization, bypass and global ischemic time. There were two operative deaths (1 SJ, 1 MH). Clinical performance and Dobutamine stress transesophageal doppler echocardiography could not demonstrate a significant advantage of one prosthesis over the other in this population. The change in aortic valve gradient, and left ventricular mass index measured preoperatively and within 12 months postoperatively were not different in both cohorts. CONCLUSION The study could not detect a difference in the performance of the SJ and MH heart valves for aortic valve replacement in patients with small aortic annuli.

Exercise Evaluation of Prosthetic Heart Valves by Doppler Echocardiography: Comparison with Catheterization Studies

Although valve replacement remains the cornerstone of treatment for critical heart valve dysfunction, problems including thromboembolism, infection, and primary failure of the prosthesis remain. Resting studies of valve hemodynamics are sometimes insufficient to reveal valve dysfunction. Early studies using cardiac catheterization focused on changes in prosthetic function seen with various types of exercise or drug‐induced stress. These studies suffered from an inability to adequately stress catheterized patients and were cumbersome to the patient and the investigator. With the introduction of Doppler echocardiography, however, studies could be performed after significant exercise with low risk and increased ease. Using echocardiography, reports of exercise‐induced changes in aortic and mitral valve hemodynamics have appeared. Over 600 patients have been studied using Doppler echocardiography. In the aortic position, all prostheses studied have a mild peak instantaneous gradient (18–26 mmHg) at rest, which increases with exercise (35–63 mmHg). No significant differences between the four models of mechanical prostheses studied are found. The gradients achieved with exercise do not appear to be related to the heart rate achieved or duration of exercise. Smaller prostheses are associated with larger gradients; however, the correlation was not strong. All mitral valve prostheses studied are also mildly stenotic at rest (range of mean gradients 2.3–7.1 mmHg) and become moderately stenotic with exercise (range 5.1–16.5). Although the lowest gradients are seen with St. Jude Medical and Medtronic Hall prostheses, their gradients are not significantly less than with other valves. Exercise duration and heart rate attained are not correlated to gradient, and valve size is not related to gradient except in the case of the larger St. Jude Medical valves. Other factors predictive of low levels of exercise tolerance are age >50 and predominant mitral regurgitation before replacement. In summary, exercise Doppler echocardiography offers a noninvasive technique to evaluate prosthetic heart valves. It is reproducible, safe, and less cumbersome than cardiac catheterization. A range of normal exercise hemodynamics has been established for aortic and mitral prostheses. Using these parameters, the diagnosis of early prosthetic dysfunction can be made.

Myocardial toxoplasmosis complicating cardiac transplant

The increase in numbers of immunocompromised patients has been reflected by an increasing frequency of opportunistic infections. Of these, Toxoplasma gondii has been reported as a significant human pathogen following cardiac transplantation. In this setting, quiescent toxoplasma myocardial cysts may become active after implantation into a therapeutically immunosuppressed host. The consequences of infection are significant and carry a high morbidity and mortality. We present the clinical and pathologic characteristics of a patient with toxoplasma infection complicating cardiac transplant and review previously reported cases of this entity.

Pharmacologic stress-induced regional myocardial blood flow heterogeneity and left ventricular wall thickening abnormality: Comparison of intravenous adenosine with dipyridamole in a model of critical coronary stenosis

Variations in reported sensitivity of myocardial perfusion scans or wall motion abnormalities during pharmacologic stress with intravenous adenosine and dipyridamole may be caused by differences in myocardial oxygen demand or myocardial blood flow redistribution induced by each agent. To investigate the physiologic correlates of functional abnormalities during pharmacologic stress testing, regional myocardial blood flow (radiolabeled microsphere technique) and left ventricular segmental wall thickening (quantitative two-dimensional echocardiography) were measured in 9 dogs with an open chest model of critical stenosis of the left circumflex coronary artery. Data were obtained at baseline and peak drug infusion for intravenous adenosine (0.42 mg/kg over a 3-minute period) and for intravenous dipyridamole (0.56 mg/kg over a 4-minute period). Adenosine and dipyridamole induced regional flow abnormality in 7 (77%) of 9 dogs. Myocardial segments with decreased endocardial/epicardial flow ratio were similar for both agents (2.9 +/- 1.8 vs 2.7 +/- 1.3, p = [NS]). Segments with myocardial flow heterogeneity (ratio of endocardial flow to control left anterior descending/left circumflex endocardial flow) were similar for both agents (2.7 +/- 0.9 vs 2.3 +/- 1.0, p = NS). Adenosine-induced wall thickening abnormality (77% vs 55% with dipyridamole) correlated with regional flow abnormality. Significantly lower mean arterial pressure (53 +/- 1.7 mm Hg vs 64 +/- 1.9 mm Hg, p < 0.01) and more prolonged drug effect (18 +/- 6.4 min vs 3 +/- 1.4 min, p < 0.001) were seen for dipyridamole compared with adenosine. Adenosine induces regional flow abnormality similar to dipyridamole but with less hemodynamic perturbation, and adenosine-induced wall thickening abnormality more closely parallels regional flow abnormality.